Study of ADAMTS13 isoforms in HUVEC

被引:0
|
作者
Carrivale, M. A. [1 ]
Zapata, V. A. [1 ]
Keller, L. [1 ]
Luceros, Sanchez A. [1 ]
Kempfer, A. C. [1 ]
Lazzari, M. A. [1 ]
机构
[1] Acad Nacl Med Buenos Aires, Inst Invest Hematol Mariano Castex, Hemostasia & Trombosis, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP-WE-093
引用
收藏
页码:657 / 657
页数:1
相关论文
共 50 条
  • [31] Glycans of plasma ADAMTS13
    Vanhoorelbeke, Karen
    BLOOD, 2016, 128 (21) : 2485 - +
  • [32] Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays
    Shelat, SG
    Ai, JH
    Zheng, XL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (06): : 659 - 672
  • [33] Special delivery for ADAMTS13
    Desch, Karl
    BLOOD, 2015, 125 (21) : 3218 - 3219
  • [34] Conformational activation of ADAMTS13
    South, Kieron
    Luken, Brenda M.
    Crawley, James T. B.
    Phillips, Rebecca
    Thomas, Mari
    Collins, Richard F.
    Deforche, Louis
    Vanhoorelbeke, Karen
    Lane, David A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (52) : 18578 - 18583
  • [35] Eve of an ADAMTS13 breakthrough
    Raife, TJ
    BLOOD, 2003, 102 (09) : 3079 - 3080
  • [36] ADAMTS13 activity and inhibitor
    Doldan-Silvero, Adriana
    Acevedo-Gadea, Carlos
    Habib, Clandine
    Freeman, Jonathan
    Johari, Vandita
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) : 811 - 813
  • [37] ADAMTS13 activity in cryoprecipitate
    Scott, E. A.
    Puca, K. E.
    Pietz, B. C.
    Friedman, K. D.
    TRANSFUSION, 2006, 46 (09) : 12A - 12A
  • [38] Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels
    Ma, Qianyi
    Jacobi, Paula M.
    Emmer, Brian T.
    Kretz, Colin A.
    Ozel, Ayse Bilge
    McGee, Beth
    Kimchi-Sarfaty, Chava
    Ginsburg, David
    Li, Jun Z.
    Desch, Karl C.
    BLOOD ADVANCES, 2017, 1 (15) : 1037 - 1046
  • [39] Normalization of ADAMTS13 activity in rats with an adjusted inhibitor titer by administration of recombinant ADAMTS13
    Schiviz, Alexandra
    Plaimauer, Barbara
    Kaufmann, Stefan
    Hoebarth, Gerald
    Wolfsegger, Martin
    Muchitsch, Eva-Maria
    Turecek, Peter L.
    Scheiflinger, Friedrich
    Rottensteiner, Hanspeter
    HAEMOPHILIA, 2014, 20 : 103 - 104
  • [40] In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease
    Katneni, Upendra K.
    Holcomb, David D.
    Hernandez, Nancy E.
    Hamasaki-Katagiri, Nobuko
    Hunt, Ryan C.
    Bar, Haim
    Ibla, Juan C.
    Kimchi-Sarfaty, Chava
    THROMBOSIS RESEARCH, 2020, 193 : 66 - 76